Given the emerging evidence implicating the PI3K signalling pathway in cSCC progression and its proposed combination with CDKs, we hypothesised that dual targeting of these pathways may synergistically inhibit cell proliferation and impede metastatic potential. This evidence concerns the gene PIK3CA and skin squamous cell carcinoma.